Back to Journals » Drug Design, Development and Therapy » Volume 13

A brief report of toxicity end points of HER2 vaccines for the treatment of patients with HER2+ breast cancer

Total article views   HTML views PDF downloads Totals
9,902 Dovepress* 7,805+ 1,286 9,091
PubMed Central* 2,097 288 2,385
Totals 9,902 1,574 11,476
*Since 14 January 2019

View citations on PubMed Central and Google Scholar